Similar articles

• Hydroxyurea for the treatment of sickle cell anemia.

  Platt OS. Platt OS. N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272. N Engl J Med. 2008. PMID: 18367739 Review. No abstract available.
• Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.

  Italia KY, Jijina FF, Chandrakala S, Nadkarni AH, Sawant P, Ghosh K, Colah RB. Italia KY, et al. J Clin Pharmacol. 2010 Feb;50(2):231-4. doi: 10.1177/0091270009343933. Epub 2009 Oct 1. J Clin Pharmacol. 2010. PMID: 19797538 No abstract available.
• Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.

  Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA. Covas DT, et al. Haematologica. 2004 Mar;89(3):273-80. Haematologica. 2004. PMID: 15020264 Clinical Trial.
• Hydroxyurea for sickle cell anemia.

  Naina HV, Harris S. Naina HV, et al. N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. doi: 10.1056/NEJMc080902. N Engl J Med. 2008. PMID: 18596283 No abstract available.
• Hydroxyurea therapy: improving the lives of patients with sickle cell disease.

  Anderson N. Anderson N. Pediatr Nurs. 2006 Nov-Dec;32(6):541-3. Pediatr Nurs. 2006. PMID: 17256291 Review.